Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 12
2006 54
2007 39
2008 29
2009 35
2010 6
2011 35
2012 85
2013 151
2014 191
2015 251
2016 324
2017 376
2018 256
2019 312
2020 214
2021 193
2022 227
2023 232
2024 128

Text availability

Article attribute

Article type

Publication date

Search Results

2,246 results

Results by year

Filters applied: . Clear all
Page 1
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer.
Lim EA, Schweizer MT, Chi KN, Aggarwal R, Agarwal N, Gulley J, Attiyeh E, Greger J, Wu S, Jaiprasart P, Loffredo J, Bandyopadhyay N, Xie H, Hansen AR. Lim EA, et al. Clin Genitourin Cancer. 2023 Jun;21(3):366-375. doi: 10.1016/j.clgc.2023.02.010. Epub 2023 Feb 28. Clin Genitourin Cancer. 2023. PMID: 36948922 Clinical Trial.
Corrigendum.
[No authors listed] [No authors listed] Clin Genitourin Cancer. 2024 Apr;22(2):367. doi: 10.1016/j.clgc.2023.12.006. Epub 2024 Jan 25. Clin Genitourin Cancer. 2024. PMID: 38278656 Free article. No abstract available.
Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?
Arcos MBL, López-Campos F, Valcarcel ML, Rubio MG, de Manzanos IVF, Duque-Santana V, Aparicio MG, Martin JZ, Kishan AU, Achard V, Siva S, Couñago F. Arcos MBL, et al. Clin Genitourin Cancer. 2023 Jun;21(3):e93-e103. doi: 10.1016/j.clgc.2022.10.015. Epub 2022 Nov 11. Clin Genitourin Cancer. 2023. PMID: 36456467 Review.
Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research.
Ebrahimi H, Castro DV, Feng MI, Prajapati SR, Lee KO, Chan EH, Paul T, Sehgal I, Patel J, Li X, Zengin ZB, Meza L, Mercier BD, Hsu J, Govindarajan A, Chawla N, Dizman N, Bergerot CD, Rock A, Liu S, Tripathi A, Dorff T, Pal SK, Chehrazi-Raffle A. Ebrahimi H, et al. Clin Genitourin Cancer. 2023 Dec;21(6):e467-e473. doi: 10.1016/j.clgc.2023.05.013. Epub 2023 May 24. Clin Genitourin Cancer. 2023. PMID: 37301665
ATR Inhibition in Advanced Urothelial Carcinoma.
Leibrandt RC, Tu MJ, Yu AM, Lara PN, Parikh M. Leibrandt RC, et al. Clin Genitourin Cancer. 2023 Apr;21(2):203-207. doi: 10.1016/j.clgc.2022.10.016. Epub 2022 Nov 4. Clin Genitourin Cancer. 2023. PMID: 36604210 Free PMC article. Review.
Novel Approaches in the Systemic Management of High-Risk Prostate Cancer.
Gómez-Aparicio MA, López-Campos F, Lozano AJ, Maldonado X, Caballero B, Zafra J, Suarez V, Moreno E, Arcangeli S, Scorsetti M, Couñago F. Gómez-Aparicio MA, et al. Clin Genitourin Cancer. 2023 Dec;21(6):e485-e494. doi: 10.1016/j.clgc.2023.06.001. Epub 2023 Jun 18. Clin Genitourin Cancer. 2023. PMID: 37453915 Review.
An Update on Focal Therapy for Prostate Cancer.
Ayerra Perez H, Barba Abad JF, Extramiana Cameno J. Ayerra Perez H, et al. Clin Genitourin Cancer. 2023 Dec;21(6):712.e1-712.e8. doi: 10.1016/j.clgc.2023.04.013. Epub 2023 May 3. Clin Genitourin Cancer. 2023. PMID: 37258359 Review.
Antibody-Drug Conjugates in Prostate Cancer: Where Are we?
Mjaess G, Aoun F, Rassy E, Diamand R, Albisinni S, Roumeguère T. Mjaess G, et al. Clin Genitourin Cancer. 2023 Feb;21(1):171-174. doi: 10.1016/j.clgc.2022.07.009. Epub 2022 Jul 23. Clin Genitourin Cancer. 2023. PMID: 35999150 Review.
2,246 results